Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Witold Wiecek

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Plos One|June 9, 2016
Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell CarcinomaWitold Wiecek, Helene Karcher
Archives of Toxicology|October 10, 2018
The Yin-Yang of CYP3A4: a Bayesian meta-analysis to quantify inhibition and induction of CYP3A4 metabolism in humans and refine uncertainty factors for mixture risk assessmentNadia Quignot, Witold Wiecek, Billy Amzal, et al.
Clinical and Experimental Rheumatology|November 30, 2020
Secukinumab's effect on structural damage progression in psoriatic arthritis: longitudinal mixture modelling of FUTURE-1 and FUTURE-5Olivier Luttringer, Todd Fox, Luminita Pricop, et al.
Plos One|December 16, 2017
Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approachSankarasubramanian Rajaram, Witold Wiecek, Richard Lawson, et al.
Targeted Oncology|March 2, 2018
Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-AnalysisElvira Schmidt, Johanna Lister, Monika Neumann, et al.
Human Vaccines & Immunotherapeutics|November 15, 2017
A retrospective observational analysis of post-pandemic influenza-related outcomes in the United Kingdom, 2010-2014Sankarasubramanian Rajaram, Witold Wiecek, Richard Lawson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Plos One|June 9, 2016
Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell CarcinomaWitold Wiecek, Helene Karcher
Archives of Toxicology|October 10, 2018
The Yin-Yang of CYP3A4: a Bayesian meta-analysis to quantify inhibition and induction of CYP3A4 metabolism in humans and refine uncertainty factors for mixture risk assessmentNadia Quignot, Witold Wiecek, Billy Amzal, et al.
Clinical and Experimental Rheumatology|November 30, 2020
Secukinumab's effect on structural damage progression in psoriatic arthritis: longitudinal mixture modelling of FUTURE-1 and FUTURE-5Olivier Luttringer, Todd Fox, Luminita Pricop, et al.
Plos One|December 16, 2017
Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approachSankarasubramanian Rajaram, Witold Wiecek, Richard Lawson, et al.
Targeted Oncology|March 2, 2018
Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-AnalysisElvira Schmidt, Johanna Lister, Monika Neumann, et al.
Human Vaccines & Immunotherapeutics|November 15, 2017
A retrospective observational analysis of post-pandemic influenza-related outcomes in the United Kingdom, 2010-2014Sankarasubramanian Rajaram, Witold Wiecek, Richard Lawson, et al.
Pageof 1